AllianceBernstein’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.76B | Sell |
4,427,764
-193,341
| -4% | -$196M | 1.54% | 9 |
|
|
2025
Q4 | $4.97B | Sell |
4,621,105
-188,878
| -4% | -$181M | 1.57% | 9 |
|
|
2025
Q3 | $3.67B | Sell |
4,809,983
-403,871
| -8% | -$301M | 1.16% | 10 |
|
|
2025
Q2 | $4.06B | Sell |
5,213,854
-230,065
| -4% | -$179M | 1.33% | 10 |
|
|
2025
Q1 | $4.5B | Buy |
5,443,919
+397,696
| +8% | +$331M | 1.63% | 10 |
|
|
2024
Q4 | $3.9B | Sell |
5,046,223
-11,513
| -0.2% | -$9.53M | 1.32% | 11 |
|
|
2024
Q3 | $4.48B | Buy |
5,057,736
+187,059
| +4% | +$168M | 1.51% | 9 |
|
|
2024
Q2 | $4.41B | Buy |
4,870,677
+83,103
| +2% | +$66.5M | 1.54% | 8 |
|
|
2024
Q1 | $3.72B | Sell |
4,787,574
-274,727
| -5% | -$196M | 1.32% | 9 |
|
|
2023
Q4 | $2.95B | Buy |
5,062,301
+146,722
| +3% | +$85.6M | 1.14% | 9 |
|
|
2023
Q3 | $2.64B | Buy |
4,915,579
+181,351
| +4% | +$93.4M | 1.12% | 8 |
|
|
2023
Q2 | $2.22B | Buy |
4,734,228
+180,714
| +4% | +$75.8M | 0.91% | 14 |
|
|
2023
Q1 | $1.56B | Buy |
4,553,514
+2,568,469
| +129% | +$866M | 0.67% | 24 |
|
|
2022
Q4 | $726M | Sell |
1,985,045
-139,254
| -7% | -$49.4M | 0.33% | 70 |
|
|
2022
Q3 | $687M | Buy |
2,124,299
+57,286
| +3% | +$18.2M | 0.33% | 61 |
|
|
2022
Q2 | $670M | Buy |
2,067,013
+95,909
| +5% | +$28.8M | 0.31% | 68 |
|
|
2022
Q1 | $564M | Sell |
1,971,104
-63,813
| -3% | -$16.4M | 0.22% | 89 |
|
|
2021
Q4 | $562M | Sell |
2,034,917
-124,357
| -6% | -$31.5M | 0.2% | 95 |
|
|
2021
Q3 | $499M | Buy |
2,159,274
+122,425
| +6% | +$30.2M | 0.2% | 96 |
|
|
2021
Q2 | $467M | Buy |
2,036,849
+120,812
| +6% | +$24.3M | 0.19% | 104 |
|
|
2021
Q1 | $358M | Sell |
1,916,037
-431,859
| -18% | -$84.5M | 0.16% | 129 |
|
|
2020
Q4 | $396M | Sell |
2,347,896
-160,623
| -6% | -$24M | 0.19% | 102 |
|
|
2020
Q3 | $371M | Sell |
2,508,519
-89,206
| -3% | -$13.8M | 0.2% | 93 |
|
|
2020
Q2 | $426M | Sell |
2,597,725
-84,883
| -3% | -$13M | 0.25% | 77 |
|
|
2020
Q1 | $372M | Sell |
2,682,608
-1,078,646
| -29% | -$148M | 0.27% | 75 |
|
|
2019
Q4 | $494M | Sell |
3,761,254
-1,155,529
| -24% | -$134M | 0.28% | 80 |
|
|
2019
Q3 | $550M | Buy |
4,916,783
+468,455
| +11% | +$52.2M | 0.34% | 62 |
|
|
2019
Q2 | $493M | Buy |
4,448,328
+1,205,957
| +37% | +$142M | 0.31% | 68 |
|
|
2019
Q1 | $421M | Buy |
3,242,371
+729,098
| +29% | +$88.7M | 0.27% | 76 |
|
|
2018
Q4 | $291M | Sell |
2,513,273
-178,395
| -7% | -$19.9M | 0.22% | 101 |
|
|
2018
Q3 | $289M | Sell |
2,691,668
-406,909
| -13% | -$40.7M | 0.19% | 110 |
|
|
2018
Q2 | $264M | Buy |
3,098,577
+57,850
| +2% | +$4.75M | 0.18% | 114 |
|
|
2018
Q1 | $235M | Sell |
3,040,727
-1,310,932
| -30% | -$106M | 0.17% | 126 |
|
|
2017
Q4 | $368M | Buy |
4,351,659
+365,011
| +9% | +$31.1M | 0.26% | 90 |
|
|
2017
Q3 | $341M | Buy |
3,986,648
+429,728
| +12% | +$35.2M | 0.26% | 98 |
|
|
2017
Q2 | $293M | Buy |
3,556,920
+79,549
| +2% | +$6.49M | 0.23% | 104 |
|
|
2017
Q1 | $292M | Buy |
3,477,371
+808,186
| +30% | +$64.7M | 0.23% | 97 |
|
|
2016
Q4 | $196M | Buy |
2,669,185
+949,109
| +55% | +$70.7M | 0.16% | 129 |
|
|
2016
Q3 | $138M | Sell |
1,720,076
-34,107
| -2% | -$2.73M | 0.12% | 173 |
|
|
2016
Q2 | $138M | Buy |
1,754,183
+9,487
| +0.5% | +$714K | 0.12% | 178 |
|
|
2016
Q1 | $126M | Sell |
1,744,696
-44,933
| -3% | -$3.4M | 0.11% | 193 |
|
|
2015
Q4 | $151M | Sell |
1,789,629
-53,592
| -3% | -$4.45M | 0.13% | 173 |
|
|
2015
Q3 | $154M | Sell |
1,843,221
-778,222
| -30% | -$65.7M | 0.13% | 167 |
|
|
2015
Q2 | $219M | Sell |
2,621,443
-455,847
| -15% | -$34.7M | 0.18% | 129 |
|
|
2015
Q1 | $224M | Sell |
3,077,290
-527,939
| -15% | -$37.6M | 0.18% | 126 |
|
|
2014
Q4 | $249M | Sell |
3,605,229
-222,735
| -6% | -$15M | 0.21% | 115 |
|
|
2014
Q3 | $248M | Sell |
3,827,964
-59,058
| -2% | -$3.74M | 0.21% | 114 |
|
|
2014
Q2 | $242M | Sell |
3,887,022
-78,988
| -2% | -$4.71M | 0.2% | 117 |
|
|
2014
Q1 | $233M | Buy |
3,966,010
+1,690,852
| +74% | +$94.4M | 0.2% | 119 |
|
|
2013
Q4 | $116M | Sell |
2,275,158
-8,552
| -0.4% | -$428K | 0.1% | 232 |
|
|
2013
Q3 | $115M | Buy |
2,283,710
+136,471
| +6% | +$7.14M | 0.11% | 205 |
|
|
2013
Q2 | $105M | Buy |
+2,147,239
| New | +$117M | 0.11% | 199 |
|
Other funds holding LLY
VCM
VPM
AllianceBernstein's LLY Position: Q1 2026 in Review
AllianceBernstein reduced its Eli Lilly (LLY) stake by 4.2% in Q1 2026, selling an estimated $196M and leaving 4,427,764 shares worth $4.76B. The position accounts for 1.54% of the portfolio, ranked #9.
AllianceBernstein first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.97B in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- AllianceBernstein held 4,427,764 shares of Eli Lilly worth $4.76B as of Q1 2026.
- AllianceBernstein sold 193,341 Eli Lilly shares in Q1 2026, an estimated $196M.
- Eli Lilly made up 1.54% of AllianceBernstein's portfolio in Q1 2026, its #9 holding.
- AllianceBernstein first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- AllianceBernstein's Eli Lilly position peaked at $4.97B in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.